ClinicalTrials.govpublic full text
Combination Rucaparib With Nivolumab in Small Cell Lung Carcinoma
small cell lung cancer, rucaparib, nivolumab, platinum-sensitive, maintenance, sclc, immune checkpoint, parp, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 967007
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.